Last reviewed · How we verify

instilled 2% lidocaine solution

The University of Texas Health Science Center, Houston · FDA-approved active Small molecule ✓ Verified May 2026 Quality 5/100

instilled 2% lidocaine solution is a Small molecule drug developed by The University of Texas Health Science Center, Houston. It is currently FDA-approved.

Instilled 2% lidocaine solution is used to treat conditions such as postoperative air leak, interstitial cystitis, pelvic pain syndrome, cystitis, and painful bladder syndrome. The exact mechanism of action is not specified, but it is likely related to its local anesthetic properties, as indicated by its classification in ChEMBL.

At a glance

Generic nameinstilled 2% lidocaine solution
SponsorThe University of Texas Health Science Center, Houston
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about instilled 2% lidocaine solution

What is instilled 2% lidocaine solution?

instilled 2% lidocaine solution is a Small molecule drug developed by The University of Texas Health Science Center, Houston.

Who makes instilled 2% lidocaine solution?

instilled 2% lidocaine solution is developed and marketed by The University of Texas Health Science Center, Houston (see full The University of Texas Health Science Center, Houston pipeline at /company/the-university-of-texas-health-science-center-houston).

What development phase is instilled 2% lidocaine solution in?

instilled 2% lidocaine solution is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing